Lv11
10 积分 2025-07-25 加入
Anlotinib in patients with relapsed or refractory thymic epithelial tumors: a study of 50 cases
2小时前
待确认
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy + Sintilimab for Treatment-Naïve Stage IV PD-L1+ Non–Small Cell Lung Cancer Patients
1个月前
已完结
[Expert consensus on diagnosis and treatment of malignant pleural effusion caused by lung cancer]
1个月前
已完结
First-Line Zongertinib in Advanced HER2 -Mutant Non–Small-Cell Lung Cancer
3个月前
已完结
The current and emerging immunotherapy paradigm in small-cell lung cancer
5个月前
已完结
Efficacy and safety of anlotinib as maintenance therapy in patients with advanced non-small cell lung cancer achieving SD post first-line chemotherapy combined with immunotherapy
6个月前
已完结
Durvalumab, with or without tremelimumab, plus platinum–etoposide versus platinum–etoposide alone in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): updated results from a randomised, controlled, open-label, phase 3 trial
7个月前
已完结
Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial
7个月前
已完结
皖公网安备34019202002308
